INSM — Insmed Cashflow Statement
0.000.00%
Last trade - 00:00- $12.67bn
- $12.37bn
- $363.71m
Annual cashflow statement for Insmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -294 | -435 | -482 | -750 | -914 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 62.5 | 115 | 62.2 | 239 | 219 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.95 | -58.6 | 6.58 | -39.2 | -3.18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -219 | -363 | -400 | -536 | -684 |
| Capital Expenditures | -6.82 | -7.29 | -9.88 | -13.3 | -21.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -57 | -24.7 | -210 | -561 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -6.82 | -64.3 | -34.6 | -224 | -583 |
| Financing Cash Flow Items | 0 | -16.8 | -18.4 | -1.22 | -3.74 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 271 | 613 | 793 | 168 | 1,341 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 45.3 | 184 | 357 | -592 | 72.7 |